A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus

Completed

Plain-English translation of NCT03161483 on ClinicalTrials.gov ↗ · Source last updated June 2023 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(184 sites)

United States

Clinical and Translational Research Center of Alabama, PC, Tuscaloosa, Alabama

AZ Arthritis and Rheum Rsch, PLLC, Mesa, Arizona

Saint Jude Heritage Medical Center, Fullerton, California

University of California San Diego Medical Center, La Jolla, California

UCLA Division of Rheumatology, Los Angeles, California